Robodoc to enter Japanese trials:
This article was originally published in Clinica
Executive Summary
Integrated Surgical Systems (ISS) has moved a step closer to Japanese approval of its Robodoc Surgical Assistant System with approval from the Ministry of Health and Welfare to begin clinical trials in Japan. Japan is expected to be a substantial market for the Robodoc system, according to ISS' distributor, Imatron Japan, partly on the grounds that Japan has more CT and MRI systems than the US. The system is already marketed elsewhere, with 37 systems currently installed worldwide. The Japanese studies will assess up to 60 patients with a short follow-up period, and will involve the implantation of Zimmer's VerSys line of hip stem prostheses. Davis, California-based ISS said the trials could be completed by year-end, with approval forthcoming in the first half of 2001.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.